CClinicalTrials.gg
Status unknownNCT00484367Updated Aug 26, 2011

A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers

A Phase 2/3 interventional study of Adolescent group therapy and Transitional family therapy in Alcohol Abuse, Alcohol Dependence and Cannabis Abuse, sponsored by The Morton Center, Inc.. Status unknown at 1 site in United States. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2011-08-26.

Sponsored by The Morton Center, Inc. · Phase 2/3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2008), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Phase 2/3
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
All
01

Study summary

The purpose of this study is to compare the effectiveness of two psychosocially-based, manual-driven, behavioral modalities. One of these is a standardized version of the established modality of Adolescent Group Therapy (AGT), which includes both psychoeducational and therapeutic components. The other is a state-of-the-art family therapy approach, Transitional Family Therapy (TFT), which integrates management of the current problem with exploration of multigenerational issues. Both approaches have been developed to expressly target adolescent alcohol problems.

Read the detailed description

Despite well-founded societal concerns over the use of illicit drugs by youth, alcohol use has persisted for decades as the number one adolescent substance abuse problem in the U.S. Further, research has shown that the earlier the onset of alcohol use, the more likely is a person to develop alcohol dependence later, during adulthood. Consequently, the need is clear for interventions which will arrest this process at the earliest point possible. Hence, interventions that mobilize a youth's social systems to help that young person deal with the problem, i.e., the family and peer systems, would make sense from a number of standpoints. Two primary modalities developed to deal with such issues are those examined here: family therapy and group therapy.

The participants were males and females, ages 13-17 at intake, with a DSM-IV diagnosis of either alcohol abuse or alcohol dependence. Following random assignment to condition, basic treatment in both conditions was based on a 12-session model and took approximately 3-4 months, followed by 1-2 aftercare sessions over an additional 1-2 months. The treatment was provided by therapists who were already working within the community (as opposed, for instance, to graduate students). Follow-up assessments were obtained at 3 months post-treatment, 1 year post-treatment, and 2 years post-treatment, thus allowing determination of the extent to which treatment effects "held up" to a degree not attained by most of the previous outcome studies within this domain.

Comparisons: AGT and TFT are being compared on the extent to which their participants used alcohol, as well as other substances, during the three post-treatment periods. Other comparisons include school performance (grade point average), family relations/functioning, and involvement with the legal system.

02

Conditions studied

  • Alcohol Abuse
  • Alcohol Dependence
  • Cannabis Abuse
  • Cannabis Dependence
  • Other Substance Abuse

Keywords

  • Alcohol abuse
  • Substance abuse
  • Cannabis abuse
  • Adolescents
  • Group therapy
  • Family therapy
03

In context

Marijuana Abuse

517 studies on the registry are indexed under Marijuana Abuse; 114 are open to participants now.

This study's enrollment of 120 is above the median of 60 across 421 interventional studies indexed under Marijuana Abuse.

Browse Marijuana Abuse studies →

Lead sponsor

This is the only study on the registry with The Morton Center, Inc. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male and female outpatients 13-17 years of age at intake.
  • Participants had a current DSM-IV diagnosis of either alcohol abuse or alcohol dependence.
  • Participants signed a witnessed informed consent.
  • Parent or custodian of each (adolescent) participant signed a witnessed informed consent.

Exclusion criteria

Exclusion Criteria:

  • Participants who met current DSM-IV criteria for bipolar disorder, psychotic disorder, or eating disorder.
  • Enrollment in a residential substance abuse treatment program within 2 months prior to intake.
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Active comparator
    1 AGT

    Behavioral: Adolescent group therapy

  • Active comparator
    2 TFT

    Behavioral: Transitional family therapy

Interventions

  • BehavioralAdolescent group therapy

    Adolescent group therapy

  • BehavioralTransitional family therapy

    Transitional family therapy

06

What researchers measure

Primary outcomes

  1. Alcohol use Cannabis use Other substance use

    Time frame: Baseline, 3 months post-treatment, 1 year post-treatment, and 2 years post-treatment

07

Study locations

1 site
  • The Morton Center
    Louisville, Kentucky 40204, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00484367
Lead sponsor
The Morton Center, Inc.
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First posted
Jun 8, 2007
Start date
Jul 1999
Primary completion
Aug 2012 (estimated)
Completion
Aug 2012 (estimated)
Last update
Aug 26, 2011

Study contacts

Morris D. Stanton, PhD
principal investigator · The Morton Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion